Ackermann, Tobias
Shokry, Engy
Deshmukh, Ruhi https://orcid.org/0000-0002-9700-8556
Anand, Jayanthi https://orcid.org/0000-0002-8883-7299
Galbraith, Laura C A https://orcid.org/0000-0002-1396-4226
Mitchell, Louise
Rodriguez-Blanco, Giovanny https://orcid.org/0000-0002-7154-7244
Villar, Victor H https://orcid.org/0000-0003-2837-5018
Sterken, Britt Amber
Nixon, Colin https://orcid.org/0000-0002-8085-2160
Zanivan, Sara
Blyth, Karen https://orcid.org/0000-0002-9304-439X
Sumpton, David https://orcid.org/0000-0002-9004-4079
Tardito, Saverio https://orcid.org/0000-0002-5294-8683
Funding for this research was provided by:
Cancer Research UK (A31287)
Cancer Research UK (A29800)
Cancer Research UK (A29799)
Cancer Research UK (A23982)
Breast Cancer Now (2018NovPR102)
Article History
Received: 23 June 2023
Revised: 23 August 2024
Accepted: 4 September 2024
First Online: 21 October 2024
Disclosure and competing interests statement
: ST is the inventor of Plasmax<sup>TM</sup> cell culture medium. The remaining authors declare no competing interests.